These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3121 related items for PubMed ID: 2985007

  • 1. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in skin malignant tumors].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):936-42. PubMed ID: 2985007
    [Abstract] [Full Text] [Related]

  • 2. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
    [Abstract] [Full Text] [Related]

  • 3. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in malignant brain tumors].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):913-20. PubMed ID: 3885862
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase II trial of lymphoblastoid interferon in metastatic malignant melanoma.
    Goldberg RM, Ayoob M, Silgals R, Ahlgren JD, Neefe JR.
    Cancer Treat Rep; 1985 Apr; 69(7-8):813-6. PubMed ID: 4016791
    [Abstract] [Full Text] [Related]

  • 10. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Apr; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 11. [Phase II study of recombinant human leukocyte A interferon on urogenital cancer patients].
    Yoshimoto J, Tsushima T, Matsumura Y, Ohmori H, Saito N, Tanaka H, Asahi T, Ohkita K, Tanahashi T, Nanba K.
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):465-70. PubMed ID: 4004282
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
    Dorval T, Palangie T, Jouve M, Garcia-Giralt E, Israel L, Falcoff E, Schwab D, Pouillart P.
    Cancer; 1986 Jul 15; 58(2):215-8. PubMed ID: 3719515
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K.
    Gan To Kagaku Ryoho; 1984 Jun 15; 11(6):1324-31. PubMed ID: 6329104
    [Abstract] [Full Text] [Related]

  • 20. A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients.
    Sherwin SA, Knost JA, Fein S, Abrams PG, Foon KA, Ochs JJ, Schoenberger C, Maluish AE, Oldham RK.
    JAMA; 1982 Nov 19; 248(19):2461-6. PubMed ID: 6752447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 157.